| Autor: |
Finke J; University Medical Center and Medical Faculty, University of Freiburg, Breisgau, Germany. juergen.finke@uniklinik-freiburg.de., Schmoor C; Clinical Trials Unit, Medical Center and Faculty of Medicine, University of Freiburg, Breisgau, Germany., Ayuk F; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hasenkamp J; University Medical Center Göttingen, Göttingen, Germany., Verbeek M; Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Clinic and Policlinic for Internal Medicine III. München, Munich, Germany., Wagner EM; University Medical Center Mainz, Mainz, Germany., Biersack H; Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck, Germany.; Klinikum Kulmbach, Bavaria, Germany., Schäfer-Eckart K; Medical Center Nürnberg Nord, Nürnberg, Germany., Wolf D; Medical Clinic 3, Universitätsklinikum Bonn, Bonn, Germany.; Dpt. Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Innsbruck, Austria., Stuhler G; DKD Helios Klinik Wiesbaden, Wiesbaden, Germany.; Universätsklinikum Würzburg, Würzburg, Germany., Reibke R; University Medical Center LMU München, Munich, Germany., Schmid C; Klinikum Augsburg, Augsburg, Germany., Kaufmann M; Robert Bosch Krankenhaus Stuttgart, Stuttgart, Germany., Eder M; University Medical Center Hannover, Hannover, Germany., Bertz H; University Medical Center and Medical Faculty, University of Freiburg, Breisgau, Germany., Grishina O; Clinical Trials Unit, Medical Center and Faculty of Medicine, University of Freiburg, Breisgau, Germany. |
Full text from SpringerLink